Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M825Revenue (TTM) $M42.8Net Margin (%)-431.9Altman Z-Score-5.5
Enterprise Value $M810EPS (TTM) $-1.7Operating Margin %-286.5Piotroski F-Score2
P/E(ttm)--Beneish M-Score-31.8Pre-tax Margin (%)-431.7Higher ROA y-yN
Price/Book32.210-y EBITDA Growth Rate %--Quick Ratio5.2Cash flow > EarningsY
Price/Sales17.65-y EBITDA Growth Rate %29.3Current Ratio5.8Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-111.0Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-1,206.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M119ROIC % (ttm)-871.2Gross Margin Increase y-yN

Gurus Latest Trades with KERX

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

KERX is held by these investors:



KERX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Madison GregPresident and CEO 2017-07-31Sell4,131$7.14-3.22view
Adams BrianGeneral Counsel and Secretary 2017-07-31Sell1,445$7.14-3.22view
Holmes Scott ACFO 2017-07-31Sell1,445$7.14-3.22view
Neylan John F.Chief Medical Officer 2017-07-31Sell1,445$7.14-3.22view
Holmes Scott ACFO 2017-07-28Sell1,236$6.96-0.72view
Neylan John F.Chief Medical Officer 2017-07-24Sell1,214$7.27-4.95view
Adams BrianGeneral Counsel and Secretary 2017-07-05Sell641$7.67-9.91view
Madison GregPresident and CEO 2017-07-05Sell910$7.67-9.91view
Madison GregPresident and CEO 2017-05-01Sell4,122$5.9715.75view
Neylan John F.Chief Medical Officer 2017-05-01Sell1,441$5.9715.75view

Press Releases about KERX :

Quarterly/Annual Reports about KERX:

News about KERX:

Articles On GuruFocus.com
Keryx Biopharmaceuticals Announces Changes to its Board of Directors Sep 13 2017 
Keryx Biopharmaceuticals to Webcast its Presentations at Investor Healthcare Conferences in Septembe Sep 05 2017 
Keryx Biopharmaceuticals to Webcast its Presentation at Canaccord Genuity’s 37th Annual Growth Aug 04 2017 
Keryx Biopharmaceuticals to Host Conference Call of Second Quarter 2017 Financial Results on Thursda Jul 19 2017 
Keryx Biopharmaceuticals to Webcast its Presentation at Jefferies’ 2017 Healthcare Conference o May 30 2017 
Keryx Biopharmaceuticals Announces First Quarter 2017 Financial Results May 04 2017 
Keryx Announces that Auryxia® (Ferric Citrate) is Now on Formulary at All Major Medicare Part D P May 01 2017 
Keryx Biopharmaceuticals to Host Conference Call of First Quarter 2017 Financial Results on Thursday Apr 18 2017 
Keryx Announces the Largest Medicare Part D Plan Sponsor Added Auryxia® to its Medicare Part D Pl Mar 20 2017 
Keryx Biopharmaceuticals Announces U.S. FDA Filing Acceptance of Supplemental New Drug Application f Mar 08 2017 

More From Other Websites
Here's Why These 3 Biotech Stocks Might Stop Rallying Sep 20 2017
Keryx Biopharmaceuticals, Inc. (KERX) Catches Eye: Stock Jumps 5.9% Sep 18 2017
Keryx Biopharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : KERX-US :... Sep 15 2017
Keryx Biopharmaceuticals Announces Changes to its Board of Directors Sep 13 2017
Keryx Biopharmaceuticals to Webcast its Presentations at Investor Healthcare Conferences in... Sep 05 2017
Keryx Biopharmaceuticals, Inc. – Value Analysis (NASDAQ:KERX) : September 2, 2017 Sep 01 2017
Keryx Biopharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : KERX-US :... Aug 29 2017
Edited Transcript of KERX earnings conference call or presentation 27-Jul-17 12:00pm GMT Aug 13 2017
ETFs with exposure to Keryx Biopharmaceuticals, Inc. : August 11, 2017 Aug 11 2017
Keryx Biopharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : KERX-US :... Aug 07 2017
Keryx Biopharmaceuticals to Webcast its Presentation at Canaccord Genuity’s 37th Annual Growth... Aug 04 2017
3 Biotech Stocks With Big News Coming Aug 02 2017
Keryx Biopharmaceuticals, Inc. :KERX-US: Earnings Analysis: Q2, 2017 By the Numbers : July 28, 2017 Jul 28 2017
Keryx (KERX) Posts Wider than Expected Loss in Q2, Sales Beat Jul 28 2017
Keryx Biopharma reports 2Q loss Jul 27 2017
ETFs with exposure to Keryx Biopharmaceuticals, Inc. : July 27, 2017 Jul 27 2017
Keryx Biopharmaceuticals Announces Second Quarter 2017 Financial Results and Increased 2017 U.S.... Jul 27 2017
3 Beaten-Up Biotechs Bouncing Back in 2017 (Hint: One Is a Marijuana Stock) Jul 23 2017
What to Expect from Keryx (KERX) this Earnings Season? Jul 21 2017
Biotech Bulletin of the Week: Gilead Sciences, Inc. (GILD), Vertex Pharmaceuticals Incorporated... Jul 20 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}